People with NSCLC are asked to participate in a research study being conducted by Monter Cancer Center.

You may be eligible to participate in this study if you:

  • Are a male or female at least 18 years of age
  • Have received Osimertinib and have had disease progression while on Osimertinib
  • Have advanced NSCLC that is not amenable to surgical resection or other approved therapeutic options that have demonstrated clinical benefit
  • Have adequate renal and hepatic function
  • Have adequate bone marrow function

You may NOT participate in this study if you:

  • Have had anti-cancer therapy within a period of 21 days prior to the first dose of the M14-237 study drug
  • Have known active COVID-19 infection
  • Have a history of interstitial lung disease (ILD) or pneumonitis
  • Have had major surgery within 21 days prior to the first dose of ABBV-399
  • Are pregnant or breastfeeding

Contact Information
Edison Sham, Study Coordinator
450 Lakeville Road Lake Success, NY 11042
Phone: (516) 734-7629
Email: esham@northwell.edu